Platelet aggregation is a process where human platelet cells are involved in hemostasis, bleeding to repair, and vessel constriction. In addition, in conjunction with other cells they play a crucial role in the inflammation and other pathological situations. Platelet aggregation is a biological process which is mediated by a platelet activation factor (PAF). Platelet aggregation test involves venipuncture in an appropriate anti-coagulant medium, followed by centrifugation to produce plasma which is rich in platelets, where aggregometers are used to study the platelet aggregation.
The inhibitory activity of the compounds is utilized for the assessment. Platelet function tests find application in pre-surgery tests; diagnose platelet dysfunction, monitoring anti-platelet therapy etc. Platelet aggregation is one of the various types of Platelet function tests. Platelet aggregation involves a set of medical devices, which allow precise control over the dynamic differential rate of blood flow control along with the extent of platelet thrombus formation.
The Platelet Aggregation Devices Market has been segmented based on device type, platelet function analyzer (PFA), aggregometers, platelet function centrifuge, platelet collection systems, and consumables & accessories. PFA is the most commonly used medical device for platelet aggregation. It is meant for aspirating in-vitro blood from the sample into cartridge test via a microscopic aperture, which is cut into biologically active collagen or epinephrine membrane on capillary ends. The PFA test reveals platelet function and number along with other specific elements.
Request to View Brochure of Report -
On the basis of end users, platelet aggregation devices market can be segmented into hospitals, diagnostic laboratories, medical research institutes and CROs, other end users (blood banks, companies engaged in clinical trials for platelet disorders). Geographically, North America (U.S and Canada) dominate the platelet aggregation devices market followed by Europe as leading manufacturers of platelet aggregation devices are domiciled in these regions having majority of their operations in local regional markets. However, Asia Pacific is also one of the key lucrative markets for these devices for diagnosing epidemic diseases such as Dengue, Malaria that affect a huge chunk of population in this region.
Comments
Post a Comment